Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
562.18B
Market cap562.18B
Price-Earnings ratio
26.38
Price-Earnings ratio26.38
Dividend yield
2.30%
Dividend yield2.30%
Average volume
7.18M
Average volume7.18M
High today
$233.76
High today$233.76
Low today
$229.00
Low today$229.00
Open price
$230.47
Open price$230.47
Volume
2.34M
Volume2.34M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$149.04
52 Week low$149.04

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $233.54. The company's market cap stands at 562.18B, with a P/E ratio of 26.38 and a dividend yield of 2.3%.

On 2026-06-05, Johnson & Johnson(JNJ) stock traded between a low of $229.00 and a high of $233.76. Shares are currently priced at $233.54, which is +2.0% above the low and -0.1% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 2.34M, against a daily average of 7.18M.

During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.

JNJ News

24/7 Wall St. 3h
Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap

Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap By Drew Wood Published Jun 5, 9:18AM EDT Quick Read A...

Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap
TipRanks 3h
J&J Oncology Outlook Largely Priced In: Gerberry Reiterates Hold Rating with Unchanged $254 Price Target

Johnson & Johnson, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason Gerberry from Bank of America Securities maint...

Nasdaq 3h
Can JNJ Sustain Growth Amid Patent, Legal and China Risks?

Johnson & Johnson JNJ faces several challenges, including revenue pressure from upcoming patent expirations, unresolved legal issues related to its talc powder,...

Can JNJ Sustain Growth Amid Patent, Legal and China Risks?

Analyst ratings

65%

of 26 ratings
Buy
65.4%
Hold
30.8%
Sell
3.8%

More JNJ News

24/7 Wall St. 4h
Dividend Aristocrats on Sale: 5 Decades-Long Raisers Trading Below Target

Dividend Aristocrats on Sale: 5 Decades-Long Raisers Trading Below Target By Jeremy Phillips Published Jun 5, 8:19AM EDT Quick Read Johnson & Johnson (JNJ) ra...

Dividend Aristocrats on Sale: 5 Decades-Long Raisers Trading Below Target
New York Times 18h
Why Vikings QB J.J. McCarthy’s comments about Kyler Murray don’t concern Kevin O’Connell - The New York Times

...

Why Vikings QB J.J. McCarthy’s comments about Kyler Murray don’t concern Kevin O’Connell - The New York Times
24/7 Wall St. 1d
Without a Roth, $60,000 in Dividend Income From These 5 Stocks Means You Owe the IRS $22,200

Without a Roth, $60,000 in Dividend Income From These 5 Stocks Means You Owe the IRS $22,200 By Joel South Published Jun 4, 9:15AM EDT Quick Read Holding O an...

Without a Roth, $60,000 in Dividend Income From These 5 Stocks Means You Owe the IRS $22,200
24/7 Wall St. 1d
Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here's What It Would Take

Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here’s What It Would Take By Drew Wood Published Jun 4, 6:51AM EDT Quick Read Replac...

Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here's What It Would Take
TipRanks 2d
Johnson & Johnson presents exploratory analyses from DAHLIAS study

Johnson & Johnson announced new biomarker exploratory analyses from the Phase 2 DAHLIAS study evaluating nipocalimab in adults with moderate-to-severe Sjogren’s...

Simply Wall St 2d
A Look At Johnson & Johnson Valuation After Recent Share Price Weakness

Advertisement Intro Johnson & Johnson (JNJ) stock has been under pressure recently, with the share price down over the past week, month, and past 3 months, pr...

A Look At Johnson & Johnson Valuation After Recent Share Price Weakness
TipRanks 3d
Johnson & Johnson Rival Medline Stock Sinks on FDA Warning over Production Practices

Medline’s (MDLN) shares dropped about 7% on Tuesday afternoon after the U.S. health watchdog issued a warning letter to the company — a medical supply rival to...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.